Back

Early detection of cardio-toxicity: the role of biomarkers.

28 May 2019 (08:48 - 09:06)
Organised by:
Congress Presentation Part of: Clinical approach to cardio-oncological patient Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Daniela Cardinale

European Institute of Oncology (IEO), Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Early detection of cardio-toxicity: the role of imaging.
Doctor T. Lopez Fernandez (Madrid, ES)
Slides Video
Presentation thumbnail
Prevention of cardiotoxicity.
Doctor K. Keramida (Athens, GR)
Slides Video
Presentation thumbnail
Medical Interventions.
Professor R. De Boer (Rotterdam, NL)
Presentation thumbnail
How to start a cardio-oncology service.
Doctor A. Lyon (London, GB)
Slides Video

Access the full session

Session thumbnail
Clinical approach to cardio-oncological patient

The Event

Event poster

Heart Failure 2019

28 May 2019 08:48 CET
You may be interested in
thumbnail
Congress Presentation
Biomarkers' ability to predict cardiac toxicity in oncological patients undergoing to antineoplastic treatment: 5-year follow-up
28 August 2020
thumbnail
Congress Session
Cardio-oncology: when therapy leads to failure
17 May 2025
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Initial phase of anthracycline cardiotoxicity involves metabolic switch and activation of cardiac fibroblasts
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources